title: Impulse control disorders induced by rasagiline as adjunctive therapy for Parkinson's disease: report of 2 cases.
authors.forename: Carmine
authors.initials: C
authors.lastname: Vitale
authors.forename: Gabriella
authors.initials: G
authors.lastname: Santangelo
authors.forename: Roberto
authors.initials: R
authors.lastname: Erro
authors.forename: Domenico
authors.initials: D
authors.lastname: Errico
authors.forename: Fiore
authors.initials: F
authors.lastname: Manganelli
authors.forename: Ilaria
authors.initials: I
authors.lastname: Improta
authors.forename: Marcello
authors.initials: M
authors.lastname: Moccia
authors.forename: Paolo
authors.initials: P
authors.lastname: Barone
mesh_terms: D000368:Aged; D000978:Antiparkinson Agents / Q000627:therapeutic use; D007174:Disruptive, Impulse Control, and Conduct Disorders / Q000139:chemically induced*; D006801:Humans; D007189:Indans / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D018696:Neuroprotective Agents / Q000009:adverse effects*; D010300:Parkinson Disease / Q000188:drug therapy*
chemical_list: D000978:Antiparkinson Agents; D007189:Indans; D018696:Neuroprotective Agents; C031967:rasagiline